DNA ligase IV as a new molecular target for temozolomide

Biochemical and Biophysical Research Communications

Volumn 387, Issue 4, 2009, Pages 656-660

  Kondo, Natsuko ^a   Takahashi, Akihisa ^a   Mori, Eiichiro ^a   Ohnishi, Ken ^a   McKinnon, Peter J ^b   Sakaki, Toshisuke ^a   Nakase, Hiroyuki ^a   Ohnishi, Takeo ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

DSB; HR; Lig4; NHEJ; TMZ

Indexed keywords

DNA LIGASE IV; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; EMBRYO; GENE; GENE CONTROL; GLIOBLASTOMA; HUMAN; HUMAN CELL; LIG4 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAD54 GENE; XRCC GENE;

ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; DACARBAZINE; DNA BREAKS, DOUBLE-STRANDED; DNA LIGASES; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS;

EID: 68549134901     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.045     Document Type: Article

References (32)

1. Chaney S.G., and Sancar A. DNA repair: enzymatic mechanisms and relevance to drug response. J. Natl. Cancer Inst. 88 (1996) 1346-1360
2. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., and Mirimanoff R.O. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352 (2005) 987-996
3. Yung W.K., Prados M.D., Yaya-Tur R., Rosenfeld S.S., Brada M., Friedman H.S., Albright R., Olson J., Chang S.M., O'Neill A.M., Friedman A.H., Bruner J., Yue N., Dugan M., Zaknoen S., and Levin V.A. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J. Clin. Oncol. 17 (1999) 2762-2771
4. Tentori L., and Graziani G. Pharmacological strategies to increase the antitumor activity of methylating agents. Curr. Med. Chem. 9 (2002) 1285-1301
5. Wood R.D., Mitchell M., Sgouros J., and Lindahl T. Human DNA repair genes. Science 291 (2001) 1284-1289
6. Day III R.S., Ziolkowski C.H., Scudiero D.A., Meyer S.A., Lubiniecki A.S., Girardi A.J., Galloway S.M., and Bynum G.D. Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature 288 (1980) 724-727
7. 6-benzylguanine-mediated enhancement of chemotherapy. Mol. Cancer Ther. 1 (2002) 943-948
8. 6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. Clin. Cancer Res. 7 (2001) 421-428
9. Bocangel D.B., Finkelstein S., Schold S.C., Bhakat K.K., Mitra S., and Kokkinakis D.M. Multifaceted resistance of gliomas to temozolomide. Clin. Cancer Res. 8 (2002) 2725-2734
10. 6-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs, DNA Repair (Amst.) 8 (2009) 72-86.
11. T. Helleday, J. Lo, D.C. van Gent, B.P. Engelward, DNA double-strand break repair: from mechanistic understanding to cancer treatment, DNA Repair (Amst.) 6 (2007) 923-935.
12. Takahashi A., Matsumoto H., Nagayama K., Kitano M., Hirose S., Tanaka H., Mori E., Yamakawa N., Yasumoto J., Yuki K., Ohnishi K., and Ohnishi T. Evidence for the involvement of double-strand breaks in heat-induced cell killing. Cancer Res. 64 (2004) 8839-8845
13. Windhofer F., Wu W., and Iliakis G. Low levels of DNA ligases III and IV sufficient for effective NHEJ. J. Cell Physiol. 213 (2007) 475-483
14. Ohnishi K., Nagata Y., Takahashi A., Taniguchi S., and Ohnishi T. Effective enhancement of X-ray-induced apoptosis in human cancer cells with mutated p53 by siRNA targeting XIAP. Oncol. Rep. 20 (2008) 57-61
15. Adachi N., Ishino T., Ishii Y., Takeda S., and Koyama H. DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: implications for DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 98 (2001) 12109-12113
16. Adachi N., Suzuki H., Iiizumi S., and Koyama H. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage. J. Biol. Chem. 278 (2003) 35897-35902
17. Li B., Navarro S., Kasahara N., and Comai L. Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1. J. Biol. Chem. 279 (2004) 13659-13667
18. Wang M., Wu W., Wu W., Rosidi B., Zhang L., Wang H., and Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 34 (2006) 6170-6182
19. Mahajan K.N., Nick McElhinny S.A., Mitchell B.S., and Ramsden D.A. Association of DNA polymerase μ (pol μ) with Ku and ligase IV: role for pol μ in end-joining double-strand break repair. Mol. Cell Biol. 22 (2002) 5194-5202
20. Takagi Y., Hidaka M., Sanada M., Yoshida H., and Sekiguchi M. Different initial steps of apoptosis induced by two types of antineoplastic drugs. Biochem. Pharmacol. 76 (2008) 303-311
21. 6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells. Cancer Res. 67 (2007) 580-584
22. 6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer 75 (1995) 1339-1342
23. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59 (1999) 793-797
24. 6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Bioessays 24 (2002) 255-266
25. Shim K.S., Schmutte C., Tombline G., Heinen C.D., and Fishel R. hXRCC2 enhances ADP/ATP processing and strand exchange by hRAD51. J. Biol. Chem. 279 (2004) 30385-30394
26. Tan T.L., Essers J., Citterio E., Swagemakers S.M., de Wit J., Benson F.E., Hoeijmakers J.H., and Kanaar R. Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation. Curr. Biol. 9 (1999) 325-328
27. E. Weterings, D.C. van Gent, The mechanism of non-homologous end-joining: a synopsis of synapsis, DNA Repair (Amst.) 3 (2004) 1425-1435.
28. Thode S., Schafer A., Pfeiffer P., and Vielmetter W. A novel pathway of DNA end-to-end joining. Cell 60 (1990) 921-928
29. Takahashi A., and Ohnishi T. Does γH2AX foci formation depend on the presence of DNA double strand breaks?. Cancer Lett. 229 (2005) 171-179
30. T. Ohnishi, E. Mori, A. Takahashi, DNA double-strand breaks: their production, recognition, and repair in eukaryotes, Mutat. Res., in press.
31. A. Takahashi, N. Yamakawa, T. Kirita, K. Omori, N. Ishioka, Y. Furusawa, E. Mori, K. Ohnishi, T. Ohnishi, DNA damage recognition proteins localize along heavy ion induced tracks in the cell nucleus, J. Radiat. Res. (Tokyo) 49 (2008) 645-652.
32. 6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J. Neurochem. 96 (2006) 766-776